Heartflow, Inc. (NASDAQ:HTFL) Stock Has Average Target Price of $48.62

Heartflow, Inc. (NASDAQ:HTFL) has earned an average rating of “Moderate Buy” from the twelve research firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $48.62.

Several analysts have recently commented on the stock. Stifel Nicolaus lifted their price target on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. JPMorgan Chase & Co. upped their price objective on Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Wells Fargo & Company lifted their target price on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Piper Sandler reissued an “overweight” rating and set a $64.00 price objective (up from $45.00) on shares of Heartflow in a research report on Tuesday, October 20th. Finally, Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th.

Heartflow Trading Down 8.5%

NASDAQ:HTFL opened at $51.77 on Friday. The firm has a fifty day simple moving average of $51.19 and a 200-day simple moving average of $34.55. Heartflow has a 12 month low of $20.13 and a 12 month high of $60.56.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million during the quarter. The business’s revenue for the quarter was up 47.7% on a year-over-year basis. On average, sell-side analysts predict that Heartflow will post -0.75 earnings per share for the current year.

Insider Transactions at Heartflow

In other news, insider Campbell Rogers sold 23,933 shares of the stock in a transaction dated Thursday, October 22nd. The stock was sold at an average price of $55.01, for a total value of $1,316,554.33. Following the transaction, the insider owned 73,453 shares in the company, valued at approximately $4,040,649.53. This represents a 24.58% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Farquhar sold 38,900 shares of the firm’s stock in a transaction dated Monday, October 12th. The stock was sold at an average price of $49.57, for a total value of $1,928,273.00. Following the sale, the chief executive officer directly owned 283,014 shares in the company, valued at $14,029,003.98. This trade represents a 12.08% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 328,038 shares of company stock valued at $15,490,354. 7.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Heartflow

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. GAMMA Investing LLC raised its stake in shares of Heartflow by 75.1% during the third quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock worth $32,000 after purchasing an additional 275 shares during the last quarter. IFP Advisors Inc grew its position in Heartflow by 844.7% in the 3rd quarter. IFP Advisors Inc now owns 803 shares of the company’s stock valued at $40,000 after buying an additional 718 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in Heartflow in the 2nd quarter valued at $53,000. Essential Partners LLC acquired a new position in Heartflow in the 1st quarter valued at $57,000. Finally, Sterling Capital Management LLC raised its position in Heartflow by 797.9% during the 3rd quarter. Sterling Capital Management LLC now owns 2,532 shares of the company’s stock worth $126,000 after buying an additional 2,250 shares during the last quarter.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries and provide noninvasive assessments of blood flow and disease.

The company’s products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.